World Health Organization (adapted from reference [14]) |
One of the following: |
Diabetes mellitus |
Impaired glucose tolerance |
Impaired fasting glucose |
Plus any two of the following |
Waist-to-hip ratio >0.9 (men) or >0.85 (women); BMI>30; or both |
Triacylglycerols ≥ 1.7 mmol/L; HDL cholesterol <0.9 mmol/L (men) or <1.0 mmol/L (women); or both |
Blood pressure ≥ 140/90 mmHg |
Microalbuminuria (urinary albumin excretion rate ≥ 20 μg/min or albumin/creatinine ratio ≥ 30 mg/g) |
National Cholesterol Education Program Adult Treatment Panel III (adapted from reference [15]) |
Any three of the following: |
Fasting glucose ≥ 6.1 mmol/L |
Waist circumference >102 cm (men) or >88 cm (women) |
Triacylglycerols ≥ 1.7 mmol/L |
HDL cholesterol <1.036 mmol/L (men) or <1.295 mmol/L (women) |
Blood pressure ≥ 130/85 mmHg |
International Diabetes Federation (adapted from reference [16]) |
Must have: |
Waist circumference as defined by sex- and ethnic-specific values |
Plus any two of the following: |
Triacylglycerols ≥ 1.7 mmol/L or treatment |
HDL <1.03 mmol/L (men) or <1.29 mmol/L (women) or treatment |
Blood pressure ≥ 130/85 mmHg or treatment |
Fasting plasma glucose ≥ 5.6 mmol/L or diagnosed type 2 diabetes |
AHA/NHLBI (adapted from reference [17]) |
Any three of the following: |
Waist circumference ≥ 102 cm (men) or ≥ 88 cm (women) |
Triglycerides ≥ 1.7 mmol/L or drug treatment for elevated triglycerides |
HDL cholesterol <1.03 mmol/L (men) or <1.3 mmol/L (women) or drug treatment for reduced HDL-C |
Blood pressure ≥ 130 mmHg systolic or ≥ 85 mmHg diastolic or drug treatment |
Fasting glucose ≥ 5.6 mmol/L or treatment for elevated glucose |